Baudax Bio, Inc. financial data

Symbol
BXRXQ on OTC
Industry
Pharmaceutical Preparations
Location
490 Lapp Road, Malvern, PA
State of incorporation
PA
Fiscal year end
December 31
Former names
Recro Enterprises, Inc. (to 6/24/2019)
Latest financial report
10-Q - Q3 2023 - Nov 20, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 18.6 % -79%
Quick Ratio 18.4 % -31.8%
Debt-to-equity -178 % -104%
Return On Equity 54.5 %
Return On Assets -48.5 % +3.29%
Operating Margin -4.66K % -843%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.6M shares +118%
Common Stock, Shares, Outstanding 12.2M shares -39.2%
Entity Public Float 6.8M USD -89.2%
Common Stock, Value, Issued 122K USD -39%
Weighted Average Number of Shares Outstanding, Basic 7.99M shares +2601%
Weighted Average Number of Shares Outstanding, Diluted 7.99M shares +2601%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 353K USD -74%
Cost of Revenue 7.01M USD +187%
Research and Development Expense 7.6M USD +242%
Costs and Expenses 16.4M USD -50.3%
Operating Income (Loss) -16.4M USD -293%
Nonoperating Income (Expense) -3.72M USD -68.5%
Net Income (Loss) Attributable to Parent -7.15M USD +64.4%
Earnings Per Share, Basic 93.3 USD/shares +99.7%
Earnings Per Share, Diluted 93.3 USD/shares +99.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 363K USD -93.6%
Inventory, Net 0 USD -100%
Assets, Current 1.34M USD -88.1%
Property, Plant and Equipment, Net 3.67M USD +196%
Operating Lease, Right-of-Use Asset 2.88M USD
Intangible Assets, Net (Excluding Goodwill) 3.9M USD +95%
Goodwill 8.8M USD +314%
Other Assets, Noncurrent 829K USD -12.2%
Assets 20.6M USD +17.6%
Accounts Payable, Current 7.82M USD +117%
Employee-related Liabilities, Current 1.02M USD -52.6%
Liabilities, Current 19.1M USD -10.5%
Operating Lease, Liability, Noncurrent 2.53M USD
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 21.8M USD -41.2%
Retained Earnings (Accumulated Deficit) -189M USD -4.21%
Stockholders' Equity Attributable to Parent -10.2M USD +57.6%
Liabilities and Equity 20.6M USD +17.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.94M USD +31.8%
Net Cash Provided by (Used in) Financing Activities 3.21M USD -64.6%
Net Cash Provided by (Used in) Investing Activities -20K USD +99.7%
Common Stock, Shares Authorized 190M shares 0%
Common Stock, Shares, Issued 12.2M shares -39.2%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -730K USD +77.8%
Deferred Tax Assets, Valuation Allowance 20.8M USD +66.4%
Deferred Tax Assets, Gross 21.1M USD +65.2%
Operating Lease, Liability 2.87M USD +241%
Depreciation 148K USD +1356%
Payments to Acquire Property, Plant, and Equipment 20K USD -72.6%
Lessee, Operating Lease, Liability, to be Paid 4.93M USD +224%
Property, Plant and Equipment, Gross 4.19M USD +55%
Operating Lease, Liability, Current 341K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 702K USD +153%
Lessee, Operating Lease, Liability, to be Paid, Year One 690K USD +156%
Operating Lease, Weighted Average Discount Rate, Percent 0.17 pure -26.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.06M USD +203%
Lessee, Operating Lease, Liability, to be Paid, Year Three 724K USD +160%
Deferred Tax Assets, Operating Loss Carryforwards 18.8M USD +65.8%
Preferred Stock, Shares Issued 36.3K shares +81.3%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 745K USD +160%
Operating Lease, Payments 96K USD -26.7%
Preferred Stock, Shares Outstanding 36.3K shares +81.3%
Amortization of Intangible Assets 65K USD -97.5%
Deferred Tax Assets, Net of Valuation Allowance 301K USD +7.89%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%